Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Chronic Severe Arthritis Pain

NCT06915012 is registered in ClinicalTrials.gov with First Institute of All Medicines as lead sponsor.

NCT NCT06915012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06915012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
Lead sponsor
First Institute of All Medicines
Phase
Not applicable
Overall status
Recruiting
Start date
March 28, 2025
Completion date
December 31, 2026
Enrollment
102 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis